Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in protein analysis and quantification. Founded in 2016, Nautilus has rapidly established itself as a leader in the field, leveraging its innovative platform to provide unparalleled insights into proteomics. The company’s core offering, the Nautilus Proteomics Platform, distinguishes itself through its ability to deliver high-throughput, accurate protein measurements, which are essential for advancing drug discovery and personalised medicine. With a commitment to transforming the understanding of biology, Nautilus has achieved significant milestones, including strategic partnerships and advancements in technology that enhance its market position. As a key player in the biotechnology landscape, Nautilus Biotechnology continues to push the boundaries of scientific research, making substantial contributions to the life sciences industry.
DitchCarbon Score
How does Nautilus Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nautilus Biotechnology, Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nautilus Biotechnology, Inc.'s reported carbon emissions
Nautilus Biotechnology, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions. In the biotechnology sector, companies are increasingly recognising the importance of sustainability and are expected to adopt comprehensive strategies to address their carbon footprints. As industry standards evolve, it will be crucial for Nautilus Biotechnology to establish clear emissions reduction goals and transparent reporting practices to align with global climate initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nautilus Biotechnology, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
